Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:50 PM
NCT ID:
NCT02271204
Eligibility Criteria:
Inclusion Criteria:
* Patients had post menopausal osteoporosis
* Patients had no contraindication for bisphosphonates
* Patients had been naive for ibandronate therapy
* Patients who have signed informed consent and are willing to share their data for data analysis
Exclusion Criteria:
* Is not Ibandronate naïve
* Hypersensitivity to any component of the bisphosphonates Ibandronate;
* Administration of any investigational drug within 30 days preceding the first dose of the study drug.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02271204
Study Brief:
Protocol Section:
NCT02271204